BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 23919111)

  • 1. Chemotherapy for cholangiocarcinoma: An update.
    Ramírez-Merino N; Aix SP; Cortés-Funes H
    World J Gastrointest Oncol; 2013 Jul; 5(7):171-6. PubMed ID: 23919111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery and hepatic artery infusion therapy for intrahepatic cholangiocarcinoma.
    Scott A; Wong P; Melstrom LG
    Surgery; 2023 Jul; 174(1):113-115. PubMed ID: 36906437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial.
    Jeong H; Kim KP; Jeong JH; Hwang DW; Lee JH; Kim KH; Moon DB; Lee MA; Park SJ; Chon HJ; Park JH; Lee JS; Ryoo BY; Yoo C
    Hepatology; 2023 May; 77(5):1540-1549. PubMed ID: 37070950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma.
    Wheless M; Agarwal R; Goff L; Lockney N; Padmanabhan C; Heumann T
    Curr Treat Options Oncol; 2024 Jan; 25(1):127-160. PubMed ID: 38177560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials.
    Nara S; Esaki M; Ban D; Takamoto T; Shimada K; Ioka T; Okusaka T; Ishii H; Furuse J
    Jpn J Clin Oncol; 2020 Dec; 50(12):1353-1363. PubMed ID: 33037430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.
    Lunsford KE; Javle M; Heyne K; Shroff RT; Abdel-Wahab R; Gupta N; Mobley CM; Saharia A; Victor DW; Nguyen DT; Graviss EA; Kaseb AO; McFadden RS; Aloia TA; Conrad C; Li XC; Monsour HP; Gaber AO; Vauthey JN; Ghobrial RM;
    Lancet Gastroenterol Hepatol; 2018 May; 3(5):337-348. PubMed ID: 29548617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on management of pancreatic cancer: a literature review.
    Lai ECH; Ung AKY
    Chin Clin Oncol; 2024 May; ():. PubMed ID: 38769794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine Plus Cisplatin Versus Non-Gemcitabine and Cisplatin Regimens as Neoadjuvant Treatment for Cholangiocarcinoma Patients Prior to Liver Transplantation: An Institution Experience.
    Abdelrahim M; Esmail A; Xu J; Umoru G; Al-Rawi H; Saharia A; Abudayyeh A; Victor D; McMillan R; Kodali S; Ghobrial RM
    Front Oncol; 2022; 12():908687. PubMed ID: 35719974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current standards and future perspectives in adjuvant treatment for biliary tract cancers.
    Lamarca A; Edeline J; McNamara MG; Hubner RA; Nagino M; Bridgewater J; Primrose J; Valle JW
    Cancer Treat Rev; 2020 Mar; 84():101936. PubMed ID: 31986437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status.
    Kuriyama N; Usui M; Gyoten K; Hayasaki A; Fujii T; Iizawa Y; Kato H; Murata Y; Tanemura A; Kishiwada M; Sakurai H; Mizuno S; Isaji S
    BMC Cancer; 2020 May; 20(1):405. PubMed ID: 32393197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of systemic induction therapy in initially unresectable locally advanced intrahepatic and perihilar cholangiocarcinoma: A systematic review.
    Belkouz A; Nooijen LE; Riady H; Franken LC; van Oijen MGH; Punt CJA; Erdmann JI; Klümpen HJ
    Cancer Treat Rev; 2020 Dec; 91():102110. PubMed ID: 33075684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
    Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
    World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholangiocarcinoma Therapeutics: An Update.
    Nguyen MLT; Toan NL; Bozko M; Bui KC; Bozko P
    Curr Cancer Drug Targets; 2021; 21(6):457-475. PubMed ID: 33563168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for pancreatic cancer.
    Springfeld C; Jäger D; Büchler MW; Strobel O; Hackert T; Palmer DH; Neoptolemos JP
    Presse Med; 2019 Mar; 48(3 Pt 2):e159-e174. PubMed ID: 30879894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current role of radiotherapy and systemic therapy in the multidisciplinary treatment of cholangiocarcinoma.
    Soumarová R; Gürlich R; Hajer J; Oliverius M; Kubecová M; Šejdová M; Liberko M; Kološtová K
    Cas Lek Cesk; 2019; 158(2):78-82. PubMed ID: 31109168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of failure following surgical resection for malignant pleural mesothelioma.
    Jänne PA; Baldini EH
    Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving role of neoadjuvant therapy in rectal cancer.
    Schrag D
    Curr Treat Options Oncol; 2013 Sep; 14(3):350-64. PubMed ID: 23828092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical overview: adjuvant therapy of gastrointestinal cancer.
    Macdonald JS
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S4-11. PubMed ID: 15309508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.